Search Within

Breast Medicine Service

Formats
  1. Journal Article (2206)
  2. Meeting Abstract (1680)
  3. Review (83)
  4. Book Section (69)
  5. Editorial (44)
  6. Conference Paper (28)
  7. Guidelines (27)
  8. Correspondence (16)
  9. Miscellaneous (12)
  10. Research Letter (11)
  11. Book Whole (5)
Groups
  1. Department of Medicine (4181)
  2. Solid Tumor Oncology Division (4181)
  3. Survivorship Research (2373)
  4. GSK Faculty (1516)
  5. Population Sciences Research Program (1369)
  6. Alan and Sandra Gerry Metastasis and Tumor Ecosystems Center (1144)

More Groups

People
  1. Clifford Hudis (906)
  2. Larry Norton (762)
  3. Mark Robson (684)
  4. Neal Rosen (427)
  5. Andrew Seidman (319)
  6. Kenneth Offit (300)

More People

Years
  1. 2025 (130)
  2. 2024 (195)
  3. 2023 (168)
  4. 2022 (219)
  5. 2021 (236)
  6. 2020 (250)

More Years

Publications
  1. Journal of Clinical Oncology (828)
  2. Cancer Research (481)
  3. Breast Cancer Research and Treatment (170)
  4. Annals of Oncology (159)
  5. Clinical Cancer Research (132)
  6. Cancer (78)

More Publications

Publishers
  1. American Society of Clinical Oncology (880)
  2. American Association for Cancer Research (755)
  3. Springer (332)
  4. Elsevier Inc. (308)
  5. Oxford University Press (282)
  6. Nature Publishing Group (276)

More Publishers

Results (4181)


Citation style sort is year ascending, and then by author or title. Author ascending is default.
  • Decreasing tumor size explains some improvement in survival from localized breast cancer
    Meeting Abstract

    Elkin, E. B.; Schrag, D.; Hudis, C.; Begg, C. B.
    Journal of Clinical Oncology (2004)

    Fulltext@MSK | Save
  • Phase II trial of erlotinib (OSI-774), an epidermal growth factor receptor (EGFR)-tyrosine kinase inhibitor, and bevacizumab, a recombinant humanized monoclonal antibody to vascular endothelial growth factor (VEGF), in patients (pts) with metastatic breast cancer (MBC)
    Meeting Abstract

    Dickler, M.; Rugo, H.; Caravelli, J.; Brogi, E.; Sachs, D.; Panageas, K.; Flores, S.; Moasser, M.; Norton, L.; Hudis, C.
    Journal of Clinical Oncology (2004)

    Fulltext@MSK | Save
  • Failure of higher-dose paclitaxel to improve outcome in patients with metastatic breast cancer: Cancer and Leukemia Group B Trial 9342
    Journal Article

    Winer, E. P.; Berry, D. A.; Woolf, S.; Duggan, W.; Kornblith, A.; Harris, L. N.; Michaelson, R. A.; Kirshner, J. A.; Fleming, G. F.; Perry, M. C.; more...
    Journal of Clinical Oncology (2004)

    Fulltext@MSK | Save
  • Dose density by any other name - Reply
    Journal Article

    Citron, M. L.; Berry, D. A.; Cirrincione, C.; Hudis, C.; Norton, L.; Winer, E. P.; Gradishar, W. J.; Davidson, N. E.; Martino, S.; Livingston, R.; more...
    Journal of Clinical Oncology (2004)

    Fulltext@MSK | Save
  • Breast MRI for women with hereditary cancer risk
    Journal Article

    Robson, M. E.; Offit, K.
    JAMA - Journal of the American Medical Association (2004)

    Fulltext@MSK | Save
  • A note on competing risks in survival data analysis
    Journal Article

    Satagopan, J. M.; Ben-Porat, L.; Berwick, M.; Robson, M.; Kutler, D.; Auerbach, A. D.
    British Journal of Cancer (2004)

    Fulltext@MSK | Save
  • Proceedings of the Consensus Conference on Neoadjuvant Chemotherapy in Carcinoma of the Breast, April 26-28, 2003, Philadelphia, Pennsylvania
    Journal Article

    Schwartz, G. F.; Hortobagyi, G. N.; Consensus Conference Committee
    Cancer (2004)

    Fulltext@MSK | Save
  • Dose-dense chemotherapy in breast cancer and lymphoma
    Journal Article

    Hudis, C. A.; Schmitz, N.
    Seminars in Oncology (2004)

    Fulltext@MSK | Save
  • Epoetin alfa: Future directions and future research
    Journal Article

    Ludwig, H.; Hudis, C. A.; Goss, G.; Leyland-Jones, B.
    The Oncologist (2004)

    Fulltext@MSK | Save
  • rHuEPO and treatment outcomes: The clinical experience
    Journal Article

    Hudis, C. A.; Van Belle, S.; Chang, J.; Muenstedt, K.
    The Oncologist (2004)

    Fulltext@MSK | Save